Description
Latin name
Rabeloc
Pharmacological action
Rabelok is an antiulcer drug, an inhibitor of H + -K + -ATPase (proton pump). The mechanism of action is associated with inhibition of the enzyme H + -K + -ATPase in the parietal cells of the stomach, which leads to blocking the final stage of the formation of hydrochloric acid. This action is dose-dependent and leads to inhibition of both basal and stimulated secretion of hydrochloric acid, regardless of the nature of the stimulus.
Indications
Peptic ulcer of the stomach and duodenum in the exacerbation phase
peptic ulcer of the stomach and duodenum associated with Helicobacter pylori (in combination with antibiotics)
gastroesophageal reflux.
Contraindications
Pregnancy, lactation (breastfeeding), hypersensitivity to rabeprazole sodium or substituted benzimidazoles.
Composition
1 vial contains:
Active ingredient: rabeprazole sodium 20 mg
Excipients: mannitol 75 mg, sodium hydroxide to a pH of 11.0.
Dosage and administration
Take orally. A single dose is 10-20 mg. The frequency and duration of use depend on the indications and treatment regimen.
Side effects of the digestive system: diarrhea, nausea, abdominal pain, vomiting, flatulence, constipation rarely – dry mouth, dyspepsia, belching in isolated cases – anorexia, gastritis, stomatitis, increased liver transaminase activity.
From the side of the central nervous system and peripheral nervous system: headache, asthenia, dizziness, insomnia, rarely – nervousness, drowsiness in isolated cases – depression, visual impairment and taste sensations.
From the respiratory system: possible – rhinitis, pharyngitis, rarely cough – sinusitis, bronchitis.
Allergic reactions: rarely – skin rash in isolated cases – itching.
Other: back pain, flu-like syndrome rarely – myalgia, chest pain, chills, spasms of the calf muscles, urinary tract infection, arthralgia, fever in isolated cases – weight gain, increased sweating, leukocytosis.
º °Ñ ÑÑ ² ½ ½ ¾ ² · ° ¸ ¼ ¾ ´ ¹ÑÑ ² ¸
Ñ ¸ ¾ ´ ½ ¾ ²Ñ ¼ ½ ½ ¾ ¼ ¿Ñ ¸ ¼ ½ ½ ¸ ¸ Ñ ´ ¸ ³ ¾ ºÑ ¸ ½ ¾ ¼ ² ¾ · ¼ ¾ ¶ ½ ¾ ¿ ¾ ² Ñ ½ ¸ ( ¾Ñ ½ ± ¾ »ÑÑ ¾ ¹ ´ ¾ Ñ ¼ Ñ ½ ½ ¾ ¹) º ¾ ½Ñ ½Ñ Ñ °Ñ ¸ ¸ ´ ¸ ³ ¾ ºÑ ¸ ½ ° ² ¿ » ° · ¼ ºÑ ¾ ² ¸.
Ñ ¸ ¾ ´ ½ ¾ ²Ñ ¼ ½ ½ ¾ ¼ ¿Ñ ¸ ¼ ½ ½ ¸ ¸ Ñ º Ñ ¾ º ¾ ½ ° · ¾ » ¾ ¼ Ñ ¼ ½ÑÑ ° Ñ ÑÑ ³ ¾ ± ¸ ¾ ´ ¾ÑÑ Ñ ¿ ½ ¾ÑÑ Ñ.
Storage Conditions
In a dark place at a temperature not exceeding 25 ° C.
shelf life
2 years
Prescription conditions from
Prescription
Possible product names
TRANSFER 0.02 N1 FLAC LIOF D / R-RA V / V
TRANSFER LIOF. I / O 20MG No. 1
DRIVER LIOF. Prigot. R-RA I / O INTRODUCTION. 20 MG FL. No. 1
Rabelok vials 20 mg, 1 pc.
